Prima Vista Diagnostics Limited

Prima Vista Diagnostics Limited
Contents Page
For the year ended 31 August 2025

Statement of financial position	1
Notes to the financial statements	2

Prima Vista Diagnostics Limited
Statement of Financial Position
As at 31 August 2025

	Notes	2025 £	2024 £
Fixed assets
Tangible fixed assets	3	192	379
		192	379
Current assets
Debtors		5,306	4,360
Cash at bank and in hand		29,226	6,860
		34,532	11,220
Creditors: amount falling due within one year		(6,661)	(5,035)
Net current assets		27,871	6,185

Total assets less current liabilities		28,063	6,564
Net assets		28,063	6,564

Capital and reserves
Called up share capital		100	100
Profit and loss account		27,963	6,464
Shareholders' funds		28,063	6,564

For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the director on 02 October 2025 and were signed by:

-------------------------------
Tae Yang Kim
Director

1

Prima Vista Diagnostics Limited
Notes to the Abridged Financial Statements
For the year ended 31 August 2025

General Information

Prima Vista Diagnostics Limited is a private company, limited by shares, registered in England and Wales, registration number 15099244, registration address C/O Jermyn & Co, Unit 3 Hill Farm Kirby Road,, Kirby Bedon, Norwich, Norfolk, NR14 7DU. The trading address of the company is 12 Poppyfields, Norwich, Norfolk, NR5 9FB.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Fixtures and Fittings

33.33% Straight Line

2.	Average number of employees Average number of employees during the year was 1 (2024 : 1).

3.

Tangible fixed assets

Cost or valuation	Fixtures and Fittings	Total
	£	£
At 01 September 2024	566	566
Additions	-	-
Disposals	-	-
At 31 August 2025	566	566
Depreciation
At 01 September 2024	187	187
Charge for year	187	187
On disposals	-	-
At 31 August 2025	374	374
Net book values
Closing balance as at 31 August 2025	192	192
Opening balance as at 01 September 2024	379	379

2

Registered Number: 15099244
England and Wales
PRIMA VISTA DIAGNOSTICS LIMITED

Abridged Accounts

Period of accounts Start date: 01 September 2024 End date: 31 August 2025